Digestive Endoscopy Unit, Università Cattolica del Sacro Cuore, Gemelli University Hospital, Rome, Italy.
Gastrointest Endosc. 2011 Dec;74(6):1248-58. doi: 10.1016/j.gie.2011.08.046.
Bariatric surgery is associated with specific complications and mortality. Transoral gastroplasty (TOGA) is a transoral restrictive bariatric procedure that might offer the benefits of surgery with a reduced complication rate.
To evaluate the safety and efficacy of TOGA at 12-month follow-up.
Prospective, multicenter, single-arm trial.
Two tertiary-care referral medical centers.
This study involved 67 patients (average age 41.0 years, 47 women, baseline body mass index [BMI] 41.5 kg/m(2); 20 patients with BMI <40).
The TOGA procedures were performed by using 2 stapling devices that were used to create a small, restrictive pouch along the lesser gastric curvature. The pouch is designed to give the patient a sustained feeling of satiety after small meals.
Excess weight loss, excess BMI loss, safety, and improvements in quality of life, obesity-related comorbidities, and medication use.
Fifty-three patients were available at the 12-month follow-up. Excess BMI loss was 33.9%, 42.6%, and 44.8% at 3, 6, and 12 months, respectively. At 12 months, excess BMI loss was 52.2% for patients with a baseline BMI of <40.0 and 41.3% for patients with a baseline BMI of ≥ 40.0 (P < .05). At 12 months, hemoglobin A(1c) levels decreased from 7.0% at baseline to 5.7% (P = .01); triglyceride levels decreased from 142.9 mg/dL to 98 mg/dL (P < .0001); high-density lipoprotein levels increased from 47.0 mg/dL to 57.5 mg/dL (P < .0001). Two complications occurred: a case of respiratory insufficiency and an asymptomatic pneumoperitoneum treated conservatively.
Small number of patients. Short-term follow-up. Twenty-one percent of patients were not available for the 12-month follow-up.
The TOGA procedure allowed a substantial weight loss 1 year after the operation without severe complications. A long-term evaluation is needed before definitive conclusions can be drawn.
减重手术与特定的并发症和死亡率有关。经口胃成形术(TOGA)是一种经口限制型减重手术,可能具有手术的益处,同时降低并发症发生率。
评估 TOGA 在 12 个月随访时的安全性和疗效。
前瞻性、多中心、单臂试验。
两家三级转诊医疗中心。
本研究共纳入 67 例患者(平均年龄 41.0 岁,47 例女性,基线时体重指数 [BMI] 为 41.5 kg/m2;20 例 BMI<40)。
采用 2 个吻合器进行 TOGA 手术,在胃小弯处创建一个小的限制型袋。该袋旨在使患者在用少量食物进食后保持持续的饱腹感。
体重减轻量、体重指数减轻量、安全性以及生活质量、肥胖相关合并症和药物使用的改善情况。
53 例患者在 12 个月时可进行随访。术后 3、6 和 12 个月时的体重指数减轻量分别为 33.9%、42.6%和 44.8%。12 个月时,BMI<40 的患者体重指数减轻量为 52.2%,BMI≥40 的患者体重指数减轻量为 41.3%(P<.05)。12 个月时,血红蛋白 A1c 水平从基线时的 7.0%降至 5.7%(P=.01);甘油三酯水平从 142.9 mg/dL 降至 98 mg/dL(P<.0001);高密度脂蛋白水平从 47.0 mg/dL 增加至 57.5 mg/dL(P<.0001)。共发生 2 例并发症:1 例呼吸功能不全和 1 例无症状气腹,均经保守治疗。
患者数量较少。随访时间短。21%的患者未进行 12 个月的随访。
TOGA 手术后 1 年体重显著减轻,且无严重并发症。需要长期评估才能得出明确结论。